Randomized Clinical Trial Assessing Laryngeal Mask Airway Versus Face-mask Ventilation in Neonatal Resuscitation (LMAvsFMV)
Primary Purpose
Asphyxia Neonatorum
Status
Completed
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
Laryngeal Mask Airway
Face mask ventilation
Sponsored by
About this trial
This is an interventional treatment trial for Asphyxia Neonatorum focused on measuring Neonatal resuscitation, Laryngeal Mask Airway (LMA), Face mask ventilation (FMV), Uganda, Africa
Eligibility Criteria
Inclusion Criteria:
- estimated gestation > 34 weeks
- estimated weight > 2000 gram
- need for Positive Pressure Ventilation (PPV) at birth
Exclusion Criteria:
- still birth
- major malformations
- severe prenatal depression (Heart rate <60 1 minute after birth)
Sites / Locations
- Mulago Teaching Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Laryngeal Mask Airway
Face mask ventilation
Arm Description
Laryngeal mask airway (LMA) ventilation will be provided for newborns in this arm during the first 2.5 minutes.
Face-mask ventilation (FMV) will be provided for newborns in this arm during the first 2.5 minutes.
Outcomes
Primary Outcome Measures
time to spontaneous ventilation
To assess if the ventilation time needed for neonates with an estimated birth weight of 2 kg or above and in need of initial respiratory support can be decreased from an average of 132 seconds in infants being resuscitated using FMV (control arm) to an average ventilation time of 72 seconds for infants resuscitated with the use of LMA (interventions arm).
Secondary Outcome Measures
proportion of infants who require advanced resuscitation
To determine if use of LMA can reduce the proportion of infants who require advanced resuscitation
the proportion of infants with adverse birth outcome
To assess the proportion of infants with adverse outcome (death or hospitalization) at 24 and 48 hours of life.
Full Information
NCT ID
NCT02042118
First Posted
December 16, 2013
Last Updated
January 31, 2017
Sponsor
Centre For International Health
Collaborators
Makerere University
1. Study Identification
Unique Protocol Identification Number
NCT02042118
Brief Title
Randomized Clinical Trial Assessing Laryngeal Mask Airway Versus Face-mask Ventilation in Neonatal Resuscitation
Acronym
LMAvsFMV
Official Title
Randomized Clinical Trial Assessing Laryngeal Mask Airway (LMA) Versus Face-mask Ventilation (FMV) in Neonatal Resuscitation at Mulago Hospital, Uganda
Study Type
Interventional
2. Study Status
Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
April 2014 (Actual)
Primary Completion Date
May 2015 (Actual)
Study Completion Date
December 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre For International Health
Collaborators
Makerere University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare the use of a laryngeal mask airway (LMA) vs. face-mask ventilation (FMV) during first-line neonatal resuscitation in Mulago Hospital, Kampala, Uganda.
Detailed Description
Background: Perinatal mortality in Eastern Uganda 2007/2008 was estimated to 41/1000 pregnancies. The rate of stillbirth was 19/1000. In the whole of Uganda in 2008, neonatal deaths constituted 21% of an estimated 190,000 under five deaths, while HIV constituted only 5%. Implementing a Helping Babies Breathe (HBB) program in one centre in Tanzania resulted in almost 40 % reduction of early neonatal mortality. Introducing a neonatal intervention package even reduced the rate of stillbirths. Birth asphyxia (BA) accounted for 60% of early neonatal deaths in Haydom Lutheran Hospital, Tanzania.
The need for resuscitation is greater in the neonate than in any other age group. Providing effective positive pressure ventilation (PPV) is the single most important component of successful neonatal resuscitation (5). Ventilation is frequently initiated with face-mask ventilation (FMV) followed by endotracheal intubation (ETT) if depression continues. These techniques may be difficult to perform resulting in prolonged resuscitation. The laryngeal mask airway (LMA) may achieve initial ventilation and successful resuscitation faster than a face-mask device or ETT. Various publications and a Cochrane review has shown LMA to be as efficient as ETT. Important air leakage during FMV is an issue. LMA reduces the need for ETT. The latest generation of LMA is made of a medical-grade gel-like elastomer designed to provide an efficient seal to the larynx without an inflatable cuff. The risk for trauma is minimised. Insertion is easy with a low risk of tissue compression or dislodgement. In a study to evaluate educational intervention in the Democratic Republic of Congo, both physicians and midwifes showed a good level of expertise in LMA insertion on mannequins. Both groups almost unanimously manifested a high degree of approval of neonatal resuscitation with LMA.
Objective: To compare the use of uncuffed LMA vs. FMV during neonatal resuscitation in Mulago Hospital, Kampala, Uganda.
Study design, setting and population: A randomized clinical trial will be conducted in Mulago hospital among asphyxiated neonates in the delivery unit. Approximately 33000 babies are born in this hospital each year.
Prior to the intervention all staff in the labour ward performing resuscitation will receive training according to the HBB curriculum with a special module for training on LMA insertion.
A total of 50 neonates will be randomized into being resuscitated with FMV or LMA. A trained midwife under supervision of a paediatrician/anaesthesiologist will initiate the resuscitation. Data from the intervention will be recorded by a research assistant and by video. Resuscitation lasting more than 150 seconds will be handed over to the supervising physician. Resuscitation will be performed according to international guidelines.
Utility of study: Findings from this study will determine if uncuffed LMA can improve outcome of asphyxiated newborn in a large delivery ward where resuscitation is performed by midwifes. Data will also show us whether uncuffed LMA is superior to FMV after a training course according to the 2010 Guidelines on Neonatal Resuscitation (AHA, European Resuscitation Council [ERC], ILCOR). The Millennium Development Goals 4 (MDG-4) aims for the reduction of child mortality by two thirds from 1990 to 2015. It is crucial to explore alternative, cost-effective modalities that not only would reduce mortality, but also the burden of neurological damage in survivors.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asphyxia Neonatorum
Keywords
Neonatal resuscitation, Laryngeal Mask Airway (LMA), Face mask ventilation (FMV), Uganda, Africa
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Laryngeal Mask Airway
Arm Type
Experimental
Arm Description
Laryngeal mask airway (LMA) ventilation will be provided for newborns in this arm during the first 2.5 minutes.
Arm Title
Face mask ventilation
Arm Type
Active Comparator
Arm Description
Face-mask ventilation (FMV) will be provided for newborns in this arm during the first 2.5 minutes.
Intervention Type
Device
Intervention Name(s)
Laryngeal Mask Airway
Other Intervention Name(s)
I-gel size 1, Intersurgical Ltd, Wokingham, Berkshire,UK
Intervention Description
Laryngeal mask airway (LMA) ventilation will be provided for newborns in this arm during the first 2.5 minutes.
Intervention Type
Device
Intervention Name(s)
Face mask ventilation
Other Intervention Name(s)
Face-mask ventilation, Neonatal resuscitator
Intervention Description
Face-mask ventilation (FMV) will be provided for newborns in this arm during the first 2.5 minutes.
Primary Outcome Measure Information:
Title
time to spontaneous ventilation
Description
To assess if the ventilation time needed for neonates with an estimated birth weight of 2 kg or above and in need of initial respiratory support can be decreased from an average of 132 seconds in infants being resuscitated using FMV (control arm) to an average ventilation time of 72 seconds for infants resuscitated with the use of LMA (interventions arm).
Time Frame
one day
Secondary Outcome Measure Information:
Title
proportion of infants who require advanced resuscitation
Description
To determine if use of LMA can reduce the proportion of infants who require advanced resuscitation
Time Frame
1 day
Title
the proportion of infants with adverse birth outcome
Description
To assess the proportion of infants with adverse outcome (death or hospitalization) at 24 and 48 hours of life.
Time Frame
2 days
Other Pre-specified Outcome Measures:
Title
Proportion of times the midwife successfully inserts the LMA and deliver efficient PPV
Description
To determine if midwifes can learn to insert LMA and deliver efficient PPV.
Time Frame
1 day
Title
Proportion of times the midwife successfully deliver efficient PPV using FMV
Description
To determine the best way for midwifes that have gone through the Helping Babies Breathe (HBB) curriculum to deliver PPV
Time Frame
1 day
Title
proportion of video recordings that provides the necessary elements for QA
Description
To determine if video recording can be used for Quality assurance (QA) of resuscitation and data collection.
Time Frame
1 day
10. Eligibility
Sex
All
Maximum Age & Unit of Time
1 Hour
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
estimated gestation > 34 weeks
estimated weight > 2000 gram
need for Positive Pressure Ventilation (PPV) at birth
Exclusion Criteria:
still birth
major malformations
severe prenatal depression (Heart rate <60 1 minute after birth)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thorkild Tylleskar, MD, PhD
Organizational Affiliation
Centre for International Health, University of Bergen
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Nicolas J Pejovic, MD
Organizational Affiliation
Centre for International Health, University of Bergen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mulago Teaching Hospital
City
Kampala
Country
Uganda
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
22508912
Citation
Ersdal HL, Mduma E, Svensen E, Perlman J. Birth asphyxia: a major cause of early neonatal mortality in a Tanzanian rural hospital. Pediatrics. 2012 May;129(5):e1238-43. doi: 10.1542/peds.2011-3134. Epub 2012 Apr 16.
Results Reference
background
PubMed Identifier
22198423
Citation
Ersdal HL, Mduma E, Svensen E, Perlman JM. Early initiation of basic resuscitation interventions including face mask ventilation may reduce birth asphyxia related mortality in low-income countries: a prospective descriptive observational study. Resuscitation. 2012 Jul;83(7):869-73. doi: 10.1016/j.resuscitation.2011.12.011. Epub 2011 Dec 23.
Results Reference
background
PubMed Identifier
15846656
Citation
Grein AJ, Weiner GM. Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003314. doi: 10.1002/14651858.CD003314.pub2.
Results Reference
background
PubMed Identifier
21763393
Citation
Zhu XY, Lin BC, Zhang QS, Ye HM, Yu RJ. A prospective evaluation of the efficacy of the laryngeal mask airway during neonatal resuscitation. Resuscitation. 2011 Nov;82(11):1405-9. doi: 10.1016/j.resuscitation.2011.06.010. Epub 2011 Jul 16.
Results Reference
background
PubMed Identifier
11015505
Citation
Carbine DN, Finer NN, Knodel E, Rich W. Video recording as a means of evaluating neonatal resuscitation performance. Pediatrics. 2000 Oct;106(4):654-8. doi: 10.1542/peds.106.4.654.
Results Reference
background
PubMed Identifier
21573019
Citation
Nankabirwa V, Tumwine JK, Tylleskar T, Nankunda J, Sommerfelt H; PROMISE EBF Research Consortium. Perinatal mortality in eastern Uganda: a community based prospective cohort study. PLoS One. 2011 May 9;6(5):e19674. doi: 10.1371/journal.pone.0019674.
Results Reference
background
PubMed Identifier
27582031
Citation
Pejovic NJ, Trevisanuto D, Nankunda J, Tylleskar T. Pilot manikin study showed that a supraglottic airway device improved simulated neonatal ventilation in a low-resource setting. Acta Paediatr. 2016 Dec;105(12):1440-1443. doi: 10.1111/apa.13565.
Results Reference
result
PubMed Identifier
28912163
Citation
Pejovic NJ, Trevisanuto D, Lubulwa C, Myrnerts Hook S, Cavallin F, Byamugisha J, Nankunda J, Tylleskar T. Neonatal resuscitation using a laryngeal mask airway: a randomised trial in Uganda. Arch Dis Child. 2018 Mar;103(3):255-260. doi: 10.1136/archdischild-2017-312934. Epub 2017 Sep 14.
Results Reference
derived
Learn more about this trial
Randomized Clinical Trial Assessing Laryngeal Mask Airway Versus Face-mask Ventilation in Neonatal Resuscitation
We'll reach out to this number within 24 hrs